Terms: = Lung cancer AND WFDC2, EDDM4, HE4, WAP5, dJ461P17.6 AND Diagnosis
32 results:
1. Human epididymis protein 4, a novel potential biomarker for diagnostic and prognosis monitoring of lung cancer.
Zhang T; Chu L; Tan W; Ye C; Dong H
Clin Respir J; 2024 May; 18(5):e13774. PubMed ID: 38742362
[TBL] [Abstract] [Full Text] [Related]
2. Human epididymal protein 4 and its combined detection show good diagnostic value in lung cancer: A retrospective study.
Wu L; Chen X; Peng T; Tang E; Bai W; Chen L
Int J Biol Markers; 2024 Jun; 39(2):141-148. PubMed ID: 38619974
[TBL] [Abstract] [Full Text] [Related]
3. Factors influencing blood tumor marker concentrations in the absence of neoplasia.
Trapé J; Fernández-Galán E; Auge JM; Carbonell-Prat M; Filella X; Miró-Cañís S; González-Fernández C;
Tumour Biol; 2024; 46(s1):S35-S63. PubMed ID: 38517826
[TBL] [Abstract] [Full Text] [Related]
4. Diagnostic value of cerebrospinal fluid human epididymis protein 4 for leptomeningeal metastasis in lung adenocarcinoma.
Li X; Chen K; Li J; Tang X; Ruan H; Guan M
Front Immunol; 2024; 15():1339914. PubMed ID: 38304432
[TBL] [Abstract] [Full Text] [Related]
5. Liquid biopsy-based decision support algorithms for diagnosis and subtyping of lung cancer.
Visser E; Genet SAAM; de Kock RPPA; van den Borne BEEM; Youssef-El Soud M; Belderbos HNA; Stege G; de Saegher MEA; van 't Westeinde SC; Brunsveld L; Broeren MAC; van de Kerkhof D; Deiman BALM; Eduati F; Scharnhorst V
Lung Cancer; 2023 Apr; 178():28-36. PubMed ID: 36773458
[TBL] [Abstract] [Full Text] [Related]
6. Secreted proteins MDK, wfdc2, and CXCL14 as candidate biomarkers for early diagnosis of lung adenocarcinoma.
Li J; Li J; Hao H; Lu F; Wang J; Ma M; Jia B; Zhuo M; Wang J; Chi Y; Zhai X; Wang Y; Wu M; An T; Zhao J; Yang F; Wang Z
BMC Cancer; 2023 Jan; 23(1):110. PubMed ID: 36721112
[TBL] [Abstract] [Full Text] [Related]
7. The investigation of levels of endothelial cell-specific molecule, progranuline, clusterin, and human epididymis protein 4 in the differential diagnosis of malignant pleural effusions.
Demirbas S; Yerlikaya FH; Yosunkaya S; Can U; Celalettin K
Medicine (Baltimore); 2022 Dec; 101(52):e32471. PubMed ID: 36595996
[TBL] [Abstract] [Full Text] [Related]
8. New insights into the diagnostic characteristics and clinical application of serum biomarkers for lung cancer, and human epididymis protein 4 as a new biomarker?
Li M; Zhang Y; Jiang L; Li Y; Li G; Zhou J; Yang C; Li X; Qu W; Chen Y; Chen Q; Wang S; Xing J; Huang H
Neoplasma; 2022 May; 69(3):729-740. PubMed ID: 35471981
[TBL] [Abstract] [Full Text] [Related]
9. Flexible diagnostic measures and new cut-point selection methods under multiple ordered classes.
Feng Y; Tian L
Pharm Stat; 2022 Jan; 21(1):220-240. PubMed ID: 34449107
[TBL] [Abstract] [Full Text] [Related]
10. Elevated Serum Human Epididymis Protein 4 Is Associated With Disease Activity and Systemic Involvements in Primary Sjögren's Syndrome.
Chen J; Sun F; Bao H; Liang L; Zhan M; Yao H; He J; Liu Y
Front Immunol; 2021; 12():670642. PubMed ID: 34248951
[TBL] [Abstract] [Full Text] [Related]
11. Borderline ovarian tumors: French guidelines from the CNGOF. Part 1. Epidemiology, biopathology, imaging and biomarkers.
Huchon C; Bourdel N; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; Mathieu D'argent E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):101965. PubMed ID: 33160106
[TBL] [Abstract] [Full Text] [Related]
12. Diagnostic value of human epididymis protein 4 in malignant pleural effusion in lung cancer.
Lv M; Wang F; Wang X; Zhang C
Cancer Biomark; 2019; 26(4):523-528. PubMed ID: 31658049
[TBL] [Abstract] [Full Text] [Related]
13. he4 as a biomarker for diagnosis of lung cancer: A meta-analysis.
He YP; Li LX; Tang JX; Yi L; Zhao Y; Zhang HW; Wu ZJ; Lei HK; Yu HQ; Nian WQ; Gan L
Medicine (Baltimore); 2019 Sep; 98(39):e17198. PubMed ID: 31574828
[TBL] [Abstract] [Full Text] [Related]
14. The Application Value of Serum he4 in the diagnosis of lung cancer.
Wang Y; Wang Z; Ding Y; Sun F; Ding X
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2405-2407. PubMed ID: 31450913
[TBL] [Abstract] [Full Text] [Related]
15. The value of human epididymis protein 4 (he4) as a serum tumor marker for accurate bone metastases finding by whole-body bone scintigraphy in lung cancer patients.
Weissensteiner J; Babusikova E
Neoplasma; 2019 Nov; 66(6):1024-1030. PubMed ID: 31307200
[TBL] [Abstract] [Full Text] [Related]
16. Diagnostic and prognostic role of he4 expression in multiple carcinomas: A protocol for systematic review and meta-analysis.
Kumarasamy C; Madhav MR; Sabarimurugan S; Lakhotiya K; Pandey V; Priyadharshini T; Baxi S; Gothandam KM; Jayaraj R
Medicine (Baltimore); 2019 Jul; 98(28):e15336. PubMed ID: 31305389
[TBL] [Abstract] [Full Text] [Related]
17. Potential for the blood-based biomarkers cytokeratin 19 fragment (CYFRA 21-1) and human epididymal protein 4 (he4) to detect recurrence during monitoring after surgical resection of adenocarcinoma of the lung.
Muley T; He Y; Rolny V; Wehnl B; Escherich A; Warth A; Stolp C; Schneider MA; Meister M; Herth FJ; Dayyani F
Lung Cancer; 2019 Apr; 130():194-200. PubMed ID: 30885344
[TBL] [Abstract] [Full Text] [Related]
18. Triple test with tumor markers CYFRA 21.1, he4, and ProGRP might contribute to diagnosis and subtyping of lung cancer.
Korkmaz ET; Koksal D; Aksu F; Dikmen ZG; Icen D; Maden E; Onder S; Akbiyik F; Emri S
Clin Biochem; 2018 Aug; 58():15-19. PubMed ID: 29729229
[TBL] [Abstract] [Full Text] [Related]
19. Development and validation of a novel diagnostic nomogram model based on tumor markers for assessing cancer risk of pulmonary lesions: A multicenter study in Chinese population.
Du Q; Yan C; Wu SG; Zhang W; Huang C; Yao Y; Wang L; Zhang Q; Liu Q; Guan J; Hou Y; Li Z; Soh A; Beshiri A; Wang Q; Li X; Zheng Y; Wang H
Cancer Lett; 2018 Apr; 420():236-241. PubMed ID: 29412152
[TBL] [Abstract] [Full Text] [Related]
20. Preparation and characterization of a high-affinity monoclonal antibody against human epididymis protein-4.
Shen Y; Wang Y; Jiang X; Lu L; Wang C; Luo W; Zhang Y; Li P; Du Z; Dai T; Wu C; Fang A; Yao Y; Peng Q; Yang J
Protein Expr Purif; 2018 Jan; 141():44-51. PubMed ID: 28928083
[TBL] [Abstract] [Full Text] [Related]
[Next]
